Literature DB >> 8105362

The Myf fibrillae of Yersinia enterocolitica.

M Iriarte1, J C Vanooteghem, I Delor, R Díaz, S Knutton, G R Cornelis.   

Abstract

The Myf antigen produced by Yersinia enterocolitica appeared as a proteic polymer composed of 21 kDa subunits. By transposon mutagenesis we isolated Myf-defective mutants. Those allowed us to clone and sequence a 4.4 kb chromosomal locus involved in Myf production. This region was found to contain three genes that we called myfA, myfB and myfC. Genes myfB and myfC encode an assembly machine related to those involved in the synthesis of many fimbriae: MyfB, the putative chaperone, possesses the consensus residues of the PapD family and myfC encodes a putative outer-membrane protein. MyfA, the major subunit, was found to be 44% identical to the pH 6 antigen of Y. pestis. Myf is thus the Y. enterocolitica counterpart of this antigen, but it is by far not so well conserved as the other virulence determinants such as the Yops, suggesting that Myf and pH 6 antigen do not necessarily play the same role in Y. enterocolitica and Y. pestis. The study of the prevalence of myfA in various species of Yersinia revealed that, like the yst enterotoxin gene, its presence is restricted to the pathogenic serotypes of Y. enterocolitica. By immunogold labelling, Myf appeared as a layer of extracellular material extending locally 2 microns from the bacterial surface, indicative of a fibrillar structure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105362     DOI: 10.1111/j.1365-2958.1993.tb01712.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  35 in total

1.  The psa locus is responsible for thermoinducible binding of Yersinia pseudotuberculosis to cultured cells.

Authors:  Y Yang; J J Merriam; J P Mueller; R R Isberg
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

3.  Transcriptional activation of the tad type IVb pilus operon by PypB in Yersinia enterocolitica.

Authors:  Jennifer Schilling; Karin Wagner; Stephanie Seekircher; Lilo Greune; Verena Humberg; M Alexander Schmidt; Gerhard Heusipp
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

4.  Expression, purification, and characterization of the humoral immune response to recombinant MyfA protein of Yersinia enterocolitica.

Authors:  W Rastawicki; R Gierczyński
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-09-20       Impact factor: 3.267

5.  Transcriptional analysis of the Yersinia pestis pH 6 antigen gene.

Authors:  S B Price; M D Freeman; K S Yeh
Journal:  J Bacteriol       Date:  1995-10       Impact factor: 3.490

Review 6.  Bacterial adhesins: common themes and variations in architecture and assembly.

Authors:  G E Soto; S J Hultgren
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

7.  Molecular basis of two subfamilies of immunoglobulin-like chaperones.

Authors:  D L Hung; S D Knight; R M Woods; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Identification of virulence-associated characteristics in clinical isolates of Yersinia enterocolitica lacking classical virulence markers.

Authors:  T Grant; V Bennett-Wood; R M Robins-Browne
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

9.  Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain.

Authors:  Ascención Torres-Escobar; María Dolores Juárez-Rodríguez; Roy Curtiss
Journal:  FEMS Microbiol Lett       Date:  2009-10-22       Impact factor: 2.742

Review 10.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.